Regen BioPharma annual net debt
2016
2018
2022
2023
2024
2025
Regen BioPharma Net Debt Growth & History (RGBP)
Regen BioPharma's net debt was $966,700 for fiscal 2025.
View full Regen BioPharma company overviewRegen BioPharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $966,700 | $467,536 | +93.66% |
| 2024 | 2024-09-30 | $499,164 | −$135,003 | −21.29% |
| 2023 | 2023-09-30 | $634,167 | −$588,679 | −48.14% |
| 2022 | 2022-09-30 | $1.2M | — | — |
| 2018 | 2018-09-30 | $341,981 | — | — |
| 2016 | 2016-09-30 | $82,235 | — | — |
Regen BioPharma quarterly net debt
Q2.16
Q3.16
Q4.16
Q4.18
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $729,524 | −$304,959 | −29.48% |
| Q2 2026 | 2026-03-31 | $829,671 | −$136,199 | −14.10% |
| Q1 2026 | 2025-12-31 | $963,436 | — | — |
| Q4 2025 | 2025-09-30 | $966,700 | $467,536 | +93.66% |
| Q3 2025 | 2025-06-30 | $1.0M | — | — |
| Q2 2025 | 2025-03-31 | $965,870 | — | — |
| Q4 2024 | 2024-09-30 | $499,164 | — | — |
| Q4 2018 | 2018-09-30 | $341,981 | — | — |
| Q4 2016 | 2016-09-30 | $82,235 | — | — |
| Q3 2016 | 2016-06-30 | −$37,614 | — | — |
| Q2 2016 | 2016-03-31 | −$6,024 | — | — |
Regen BioPharma net debt trends
Between the periods ended 2016-09-30 and 2025-09-30, Regen BioPharma's net debt increased from $82,235 to $966,700, a change of $884,465. The latest reported quarter, Q3 2026, shows $729,524.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regen BioPharma source filings ↗